This Week Last Year in Medtech: May 7-13
11 May 2023
Acquisition
Is Magneto the Hero We Need to Destroy Blood Clots?
Unlike the Marvel Universe character by the same name, this Magneto is battling blood clots with a device based on electric fields.
This Company Is Reinventing the Heart Valve
Foldax is trying to eliminate the tradeoff between mechanical and tissue heart valves by starting from scratch.
Medtronic Hits an FTC Roadblock in Intersect ENT Deal
The Federal Trade Commission wants Medtronic to divest an Intersect ENT subsidiary as a condition of the deal.
Bioventus Needs to Find Another Way to Pay for CartiHeal
The company has nixed a $415 sale of senior notes that was meant to fund its acquisition of CartiHeal.
Can Globus Turn Things Around in a Competitive Spine Market?
The company will need to rebound in the second quarter to earn back investor confidence.
Could HF be Diagnosed with Just an MRI?
Researchers found that MRI could be a reliable and safe option all while avoiding an invasive procedure.
Would You Take a Poop Pill?
Fecal transplants have been proven effective at treating C. diff, but current delivery methods are lacking. Is stool encapsulation the answer?
Medtronic Wins FDA Nod for Onyx Frontier DES
The Dublin-based company said the device is the latest innovation in the Resolute DES family.
Most Anticipated New Medical Devices in 2022
These medical devices are expected to hit the U.S. market in 2022.
Elekta's Esprit Will Enable More Personalized Radio-surgery
Elekta’s new radiosurgery system, Esprit, features sub-millimeter accuracy and allows treatment planning in less than 60 seconds.
How Nufabrx Is Changing the Medical Landscape
What if your medications could be delivered by your clothing?
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.